Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001555:Benzene Derivatives / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002188:Cannabis / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002552:Cerebral Ventricles; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000494:pharmacology; D004357:Drug Synergism; D004983:Ethanolamines / Q000494:pharmacology; D005059:Euphoria / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007267:Injections; D008297:Male; D051379:Mice; D010293:Pargyline / Q000494:pharmacology; D010627:Phenethylamines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D010649:Phenylalanine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors
D001555:Benzene Derivatives; D002250:Carbon Radioisotopes; D004983:Ethanolamines; D006993:Hypnotics and Sedatives; D010627:Phenethylamines; D010649:Phenylalanine; D013759:Dronabinol; D012110:Reserpine; D010293:Pargyline